期刊文献+

肝肾移植术后结核感染差异性分析 被引量:8

Analysis of tuberculosis infection after liver and kidney transplantation
下载PDF
导出
摘要 目的探讨肝、肾移植术后结核感染患者的临床特点及治疗的差异。方法回顾性分析2002年4月-2017年10月,武警总医院器官移植科肝、肾移植术后并发结核感染的43例(肝27例、肾16例)患者的临床资料,包括临床表现、实验室及影像学检查及治疗。结果肝、肾移植术后出现结核感染率分别为1.73%、1.50%,两组结核感染率无统计学差异(P>0.05);肝、肾移植组结核感染发病时间分别为(18.25±28.12)月、(26.74±37.96)月,两组之间有统计学差异(P<0.05);两组患者大多以发热为首要表现或唯一表现,发热起病率分别为70.37%、93.75%,两组之间无统计学差异(P>0.05);两组患者均以肺为主要感染部位,肺结核率分别为51.85%、50.00%,两组之间无统计学差异(P>0.05);两组患者T-SPOT.TB阳性率分别为85.19%、81.25%,两组之间无统计学差异(P>0.05);两组患者治疗有效率分别为81.48%、81.25%,病死率分别为14.81%、12.50%,两组之间在治疗有效率及病死率方面均无统计学差异(均P>0.05)。结论肝肾移植受者术后结核感染的发生率均较高,肝移植术后结核感染发病时间早于肾移植术后患者,肝、肾移植术后并发结核感染患者免疫状态不同。两组患者经规范个体化治疗后大多能取得良好效果,但容易合并器官功能衰竭等各种严重并发症致患者死亡。 Objective To summarize the differences in clinical features and treatment between the liver transplant recipients and kidney transplant recipients. Methods The data of Clinical manifestations, laboratory examination and imaging and treatment of 43 patients who were infected TB after liver or kidney transplantation from April 2002 to October 2017 were retrospectively analyzed. Results The rates of tuberculosis infection after liver and kidney transplantation were 1.73% and 1.50%, respectively. There was no statistical difference between the two groups(P〉0.05). The time of tuberculosis infection in liver and kidney transplantation group was(18.25± 28.12) months and(26.74±37.96) respectively. There was a statistically significant difference between the groups(P〈0.05). Fever was the primary or only manifestation in both groups, and the onset rates of fever were 70.37% and 93.75%, respectively, there was no statistical difference between the two groups(P〉0.05). The rates of pulmonary tuberculosis was 51.85% and 50.00% respectively in the two groups,and there was no statistical difference between the two groups(P〉0.05). The positive rates of T-SPOT.TB in the two groups were 85.19% and 81.25%, respectively. There was no statistical difference between the two groups(P〉0.05). The effective rates of two groups were 81.48% and 81.25%, respectively, and the mortality rates were 14.81% and 12.50%,respectively. There was no significant difference between the two groups in terms of treatment efficiency and mortality(all P〈0.05). Conclusion The incidence of tuberculosis infection in liver and kidney transplant recipients are both high. The incidence of tuberculosis infection after liver transplantation is earlier than that in renal transplant recipients. The immune status of tuberculosis patients after liver and kidney transplantation is different. Most patients in both groups achieved good results after standardized individualized treatment, but they were easily died of various serious complications such as organ failure.
作者 李俊 陈虹 范铁艳 邱爽 张庆 刘艳迪 Li Jun;Chen Hong;Fan Tieyaa;Qiu Shuang;Zhang Qing;Liu Yandil(Department of Gastroenterology,Tianjin Union Medical Center,Tianfin 300121,China;Organ Transplantation Institute,General Hospital of Chinese People "s Armed Police Forces,Beijing 100039,China)
出处 《实用器官移植电子杂志》 2018年第3期183-186,共4页 Practical Journal of Organ Transplantation(Electronic Version)
基金 国家高技术发展计划(863计划)项目(2012AA021006)
关键词 肝移植 肾移植 结核 Liver transplantation Kidney transplantation Tuberculosis
  • 相关文献

参考文献3

二级参考文献31

  • 1Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management[Jl. Clin Infect Dis, 1998,27(5) : 1266-1277.
  • 2Aguado JM, Torre-Cisneros J, Fortdn J, et al. Tuberculosis insolid-organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology[J]. Clin Infect Dis, 2009,48(9):1276- 1284.
  • 3Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants[J]. Clin Infect Dis, 2005,40(4):581-587.
  • 4Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area [J]. Transplantation, 2002,74 (10) : 1381 - 1386.
  • 5Suhramanian A, Do.an S. Mycobacterium tuberculosis in solid organ transplant recipients [ J ]. Am J Transplant, 2009,9 (Suppl 4) :S57-S62.
  • 6Guggenheimer J, Eghtesad B, Stock DJ, et al. Guidelines for the prevention and management of infectious complications of solid organ transplantation [J]. Am J Transplant, 2004,4 (Suppl 10) :37-41.
  • 7Sepulveda RL, Ferret X, Latraeh C, et al. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults [J]. Am Rev Respir Dis, 1990, 142( 1 ) : 24-28.
  • 8Huebner RE, Schein MF, Bass JB Jr, et al. The tuberculin skin test[J]. Clin Infect Dis, 1993,17(6):968-975.
  • 9Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the effect of Bacille Calmette Gu6rin vaccination on tuberculin skin test measurements [ J ]. Thorax, 2002,57 (9) : 804-809.
  • 10Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion [J]. Am J Respir Crit Care Med, 1999,159(1) : 15-21.

共引文献14

同被引文献27

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部